India Business Makes Gains At Glenmark While Rest Of World Sees Mixed Results
Plus Firm Settles With Pfizer On Generic Axitinib
Glenmark’s domestic business was seen to gradually strengthen its market share during Q2, while its North American division saw a minor decline in growth and a drop in COVID-related sales took its toll.
